Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen,c3672209

Dignitana AB Appoints Nomination Committee,c3669495

Dignitana AB Publishes Q3 2022 Interim Report,c3668490

Dignitana hires Johan Johansson to Head Operations, Research and Development,c3667855

Dignitana offentliggör riktad nyemission om cirka 25 miljoner SEK,c3650780

Load More


This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Invalid OAuth access token. Type: OAuthException

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy